NSE · AI Signal & Stock Analysis · Bearish
As of Aug 14 2026, 6:50 PM, AkshayaAI's signal for AARTIPHARM is Bearish ↓ (moderate move); technical trend down-trend; trading at ₹661.10 (-1.72% today); neutral (RSI 40).
Data as of Aug 14 2026, 6:50 PM. Informational analytics only — not investment advice.
| AI signal | Bearish ↓ · Moderate move |
|---|---|
| Technical trend | Down-trend (since 2026-05-08) |
| Price | ₹661.10 |
| Change today | -1.72% |
| RSI (14) | 39.60 |
| Relative volume | 0.16 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | ₹7,719 Cr |
| P/E | 37.76 |
| Cap category | Mid Cap |
| 52-week high | -30.1% away |
| 52-week low | +11.7% above |
| Delivery volume | — |
| Sector | Drug Manufacturers - Specialty & Generic |
As of Aug 14 2026, 6:50 PM, AkshayaAI's signal for AARTIPHARM (Aarti Pharmalabs Limited) is Bearish with a moderate move, and its technical trend is down-trend. The composite score and full factor breakdown are available to signed-in members.
AARTIPHARM's RSI is neutral (RSI 40). A reading above 70 is typically overbought and below 30 oversold.
AARTIPHARM is trading about 30% below its 52-week high and 12% above its 52-week low as of Aug 14 2026, 6:50 PM.
AARTIPHARM's market capitalisation is ₹7,719 Cr as of Aug 14 2026, 6:50 PM.
AARTIPHARM is classified under Drug Manufacturers - Specialty & Generic in AkshayaAI's taxonomy.
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Aug 14 2026, 6:50 PM and may not reflect real-time prices. Always do your own research. How these signals work →
Instant, data-backed answers — free to try.